blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2588154

EP2588154 - COMPOSITION COMPRISING CALCIUM PHOSPHATE, SULFATE POWDERS OR DMB USED IN THE TREATMENT OF DEGENERATIVE BONE CONDITIONS [Right-click to bookmark this link]
Former [2013/19]COMPOSITION COMPRISING CALCIUM PHOSPHATE AND SULFATE POWDERS AND TRI - CALCIUM PHOSPHATE PARTICLES USED IN THE TREATMENT OF DEGENERATIVE BONE CONDITIONS
[2017/20]
StatusThe patent has been granted
Status updated on  15.09.2017
Database last updated on 02.11.2024
FormerGrant of patent is intended
Status updated on  12.09.2017
FormerExamination is in progress
Status updated on  01.09.2017
FormerGrant of patent is intended
Status updated on  16.05.2017
Most recent event   Tooltip13.09.2024New entry: Despatch of interlocutory decision 
Applicant(s)For all designated states
Agnovos Healthcare, LLC
7301 Calhoun Place, Suite 100
Rockville, MD 20855 / US
[2018/12]
Former [2018/11]For all designated states
Agnovos Healthcare, LLC
7301 Calhoun Drive, Suite 100
Rockville, Maryland 20855 / US
Former [2013/19]For all designated states
Agnovos Healthcare, LLC
140 Broadway, 46th Floor
New York, New York 10005 / US
Inventor(s)01 / SCHULZ, Olaf
9387 Club Walk Court
Lakeland, Tennessee 38002 / US
02 / HOWE, James
197 Beaver Creek Road
Shelburne, Vermont 05482 / US
03 / SWAIM, Rick
10178 Herons Landing Cove
Lakeland, Tennessee 38002 / US
04 / HUBER, Bryan
430 Lower Sanborn Road
Stowe, Vermont 05672 / US
05 / BATTS, Joel
625 Columnswood Way
Milton GA 30004-8246 / US
06 / HARNESS, David
1385 Canadaville Loop
Eads, Tennessee 38028 / US
07 / BELANEY, Ryan
30 Lakebreeze Cove
Oakland, Tennessee 38060 / US
 [2013/20]
Former [2013/19]01 / SCHULZ, Olaf
9387 Club Walk Court
Lakeland, Tennessee 38002 / US
02 / HOWE, James
197 Beaver Creek Road
Shelburne, Vermont 05482 / US
03 / SWAIM, Rick
10178 Herons Landing Cove
Lakeland, Tennessee 38002 / US
04 / HUBER, Bryan
430 Lower Sanborn Road
Stowe, Vermont 05672 / US
05 / BATTS, Joel
10179 Woodbrook Circle
Lakeland, Tennessee 38002 / US
06 / HARNESS, David
1385 Canadaville Loop
Eads, Tennessee 38028 / US
07 / BELANEY, Ryan
30 Lakebreeze Cove
Oakland, Tennessee 38060 / US
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2017/42]
Former [2013/19]HOFFMANN EITLE
Patent- und Rechtsanwälte
Arabellastrasse 4
81925 München / DE
Application number, filing date11734215.430.06.2011
[2017/42]
WO2011US42607
Priority number, dateTW2011012287929.06.2011         Original published format: TW 100122879
US20100361177P02.07.2010         Original published format: US 361177 P
[2013/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012003326
Date:05.01.2012
Language:EN
[2012/01]
Type: A1 Application with search report 
No.:EP2588154
Date:08.05.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 05.01.2012 takes the place of the publication of the European patent application.
[2013/19]
Type: B1 Patent specification 
No.:EP2588154
Date:18.10.2017
Language:EN
[2017/42]
Search report(s)International search report - published on:EP05.01.2012
ClassificationIPC:A61L15/28
[2024/39]
CPC:
A61B17/16 (EP,IL,KR,US); A61L24/02 (EP,CN,IL,KR,RU,US); A61L27/12 (EP,CN,IL,KR,RU,US);
A61B17/1659 (IL,KR,US); A61B17/1668 (EP,IL,KR,US); A61B17/17 (EP,IL,KR,US);
A61B5/6851 (US); A61L15/28 (EP,US); A61L24/00 (KR,RU);
A61L24/0042 (EP,CN,IL,KR,US); A61L27/02 (CN); A61L27/58 (EP,CN,IL,KR,RU,US);
A61M1/743 (US); A61M1/77 (EP,CN,IL,KR,RU,US); A61B17/3421 (US);
A61B2217/005 (IL,KR,US); A61B2217/007 (IL,KR,US); A61L2400/06 (EP,CN,IL,KR,US);
A61L2430/00 (KR); A61L2430/02 (EP,CN,IL,KR,US) (-)
Former IPC [2013/19]A61L24/00, A61L24/02, A61L27/12, A61L27/58
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/19]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ZUSAMMENSETZUNG MIT CALCIUMPHOSPHAT- , SULFATPULVERN ODER DBM ZUR BEHANDLUNG VON DEGENERATIVEN KNOCHENERKRANKUNGEN[2017/42]
English:COMPOSITION COMPRISING CALCIUM PHOSPHATE, SULFATE POWDERS OR DMB USED IN THE TREATMENT OF DEGENERATIVE BONE CONDITIONS[2017/42]
French:COMPOSITION CONTENANT DES POUDRES DE PHOSPHATE OU DE SULFATE DE CALCIUM OU DE DBM UTILISÉE POUR TRAITER DES PATHOLOGIES OSSEUSES DÉGÉNÉRATIVES[2017/42]
Former [2013/19]ZUSAMMENSETZUNG MIT CALCIUMPHOSPHAT- UND SULFATPULVERN UND TRICALCIUMPHOSPHATPARTIKELN ZUR BEHANDLUNG VON DEGENERATIVEN KNOCHENERKRANKUNGEN
Former [2013/19]COMPOSITION COMPRISING CALCIUM PHOSPHATE AND SULFATE POWDERS AND TRI - CALCIUM PHOSPHATE PARTICLES USED IN THE TREATMENT OF DEGENERATIVE BONE CONDITIONS
Former [2013/19]COMPOSITION CONTENANT DES POUDRES DE PHOSPHATE ET DE SULFATE DE CALCIUM ET DES PARTICULES DE PHOSPHATE DE TRICALCIUM UTILISÉE POUR TRAITER DES PATHOLOGIES OSSEUSES DÉGÉNÉRATIVES
Entry into regional phase31.01.2013National basic fee paid 
31.01.2013Designation fee(s) paid 
31.01.2013Examination fee paid 
Examination procedure31.01.2013Amendment by applicant (claims and/or description)
31.01.2013Examination requested  [2013/19]
29.11.2013Despatch of a communication from the examining division (Time limit: M06)
22.05.2014Reply to a communication from the examining division
11.07.2014Despatch of a communication from the examining division (Time limit: M06)
21.01.2015Reply to a communication from the examining division
11.04.2017Date of oral proceedings
12.05.2017Minutes of oral proceedings despatched
17.05.2017Communication of intention to grant the patent
28.07.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
28.07.2017Fee for grant paid
28.07.2017Fee for publishing/printing paid
12.09.2017Information about intention to grant a patent
12.09.2017Receipt of the translation of the claim(s)
Divisional application(s)EP15187629.9  / EP2987507
EP23150116.4  / EP4186534
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  29.11.2013
Opposition(s)Opponent(s)01  18.07.2018    ADMISSIBLE
Bone Support AB
Scheelevägen 19
Ideon Science Park
223 70 Lund / SE
Opponent's representative
Guardian IP Consulting I/S
Diplomvej, Building 381
2800 Kgs. Lyngby / DK
 [2018/34]
02.08.2018Invitation to proprietor to file observations on the notice of opposition
05.12.2018Reply of patent proprietor to notice(s) of opposition
26.11.2019Date of oral proceedings
07.01.2020Despatch of minutes of oral proceedings
07.01.2020Despatch of communication that the patent will be revoked
09.10.2023Despatch of a communication from the opposition division (Time limit: M04)
18.10.2023Reply to a communication from the opposition division
29.01.2024Despatch of a communication from the opposition division (Time limit: M02)
26.02.2024Reply to a communication from the opposition division
26.04.2024Despatch of a communication from the opposition division (Time limit: M02)
31.05.2024Reply to a communication from the opposition division
12.09.2024Despatch of interlocutory decision in opposition
Appeal following opposition04.03.2020Appeal received No.  T0558/20
18.05.2020Statement of grounds filed
20.04.2023Result of appeal procedure: maintenance in amended form
22.08.2023Despatch of the decision of the Board of Appeal
20.04.2023Date of oral proceedings
Fees paidRenewal fee
27.06.2013Renewal fee patent year 03
30.06.2014Renewal fee patent year 04
29.06.2015Renewal fee patent year 05
27.06.2016Renewal fee patent year 06
27.06.2017Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU30.06.2011
AL18.10.2017
AT18.10.2017
CY18.10.2017
CZ18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
MC18.10.2017
MK18.10.2017
PL18.10.2017
PT18.10.2017
RO18.10.2017
RS18.10.2017
SI18.10.2017
SK18.10.2017
SM18.10.2017
TR18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IS18.02.2018
IE30.06.2018
LU30.06.2018
MT30.06.2018
[2020/33]
Former [2020/31]HU30.06.2011
AT18.10.2017
CY18.10.2017
CZ18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
MC18.10.2017
MK18.10.2017
PL18.10.2017
PT18.10.2017
RO18.10.2017
RS18.10.2017
SI18.10.2017
SK18.10.2017
SM18.10.2017
TR18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IS18.02.2018
IE30.06.2018
LU30.06.2018
MT30.06.2018
Former [2020/27]HU30.06.2011
AT18.10.2017
CZ18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
MC18.10.2017
PL18.10.2017
PT18.10.2017
RO18.10.2017
RS18.10.2017
SI18.10.2017
SK18.10.2017
SM18.10.2017
TR18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IS18.02.2018
IE30.06.2018
LU30.06.2018
MT30.06.2018
Former [2020/16]AT18.10.2017
CZ18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
MC18.10.2017
PL18.10.2017
RO18.10.2017
RS18.10.2017
SI18.10.2017
SK18.10.2017
SM18.10.2017
TR18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IS18.02.2018
IE30.06.2018
LU30.06.2018
MT30.06.2018
Former [2020/08]AT18.10.2017
CZ18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
MC18.10.2017
PL18.10.2017
RO18.10.2017
RS18.10.2017
SI18.10.2017
SK18.10.2017
SM18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IS18.02.2018
IE30.06.2018
LU30.06.2018
MT30.06.2018
Former [2019/19]AT18.10.2017
CZ18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
MC18.10.2017
PL18.10.2017
RO18.10.2017
RS18.10.2017
SI18.10.2017
SK18.10.2017
SM18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IS18.02.2018
IE30.06.2018
LU30.06.2018
Former [2019/17]AT18.10.2017
CZ18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
MC18.10.2017
PL18.10.2017
RO18.10.2017
RS18.10.2017
SI18.10.2017
SK18.10.2017
SM18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IS18.02.2018
LU30.06.2018
Former [2019/15]AT18.10.2017
CZ18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
MC18.10.2017
PL18.10.2017
RO18.10.2017
RS18.10.2017
SI18.10.2017
SK18.10.2017
SM18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IS18.02.2018
Former [2018/52]AT18.10.2017
CZ18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
PL18.10.2017
RO18.10.2017
RS18.10.2017
SI18.10.2017
SK18.10.2017
SM18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IS18.02.2018
Former [2018/40]AT18.10.2017
CZ18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
PL18.10.2017
RO18.10.2017
RS18.10.2017
SK18.10.2017
SM18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IS18.02.2018
Former [2018/37]AT18.10.2017
CZ18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
PL18.10.2017
RS18.10.2017
SK18.10.2017
SM18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IS18.02.2018
Former [2018/24]AT18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
RS18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IS18.02.2018
Former [2018/22]FI18.10.2017
LT18.10.2017
NO18.01.2018
Cited inInternational search[X]US5108402  (CHIN ALBERT K [US]);
 [X]WO0009024  (KYPHON INC [US]);
 [A]US2002120240  (BAGGA CHARANPREET S [US], et al);
 [X]US2006190000  (SCHUTZ OLAF [US], et al);
 [X]WO2007030616  (WRIGHT MEDICAL TECH INC [US], et al)
ExaminationWO0009024
by applicantUS2115250
 US2170111
 US2229024
 US2616789
 US2706701
 US2710277
 US2826532
 US2900305
 US2977315
 US3228828
 US3573947
 US3717655
 US6652887
 US2007059281
 US7211266
 US7250550
 US7371408
 US7371409
 US7371410
 US2008300603
 US7507257
 US7658768
OppositionWO03024316
 WO2008128342
 WO2009073205
 US2010068239
 WO2012003326
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.